Skip to main content
. 2020 Dec 7;23(3):476–485. doi: 10.1002/ejhf.2060

Figure 1.

EJHF-2060-FIG-0001-c

Kaplan–Meier curves for risk of incident hospitalization/death for COVID‐19 in patients receiving vs. not receiving (A) angiotensin converting enzyme inhibitors (ACEi) or angiotensin receptor blockers (ARB) and (B) mineralocorticoid receptor antagonists (MRA). CI, confidence interval; HR, hazard ratio.